Retirement Group’s CorMedix CRMD Stock Holding History

Retirement Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-399	Closed	-$4K	–	678
2021 Q1	$4K	Buy	+399	New	+$4.2K	﹤0.01%	575

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Retirement Group's CRMD Position: Q2 2021 in Review

Retirement Group sold out of CorMedix (CRMD) in Q2 2021, closing a stake of 399 shares — an estimated $4K sold.

Retirement Group first reported a position in CRMD in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 79 funds tracked by Wall St. Rank hold CRMD as of Q2 2021.

Retirement Group reported no remaining CorMedix position as of Q2 2021 after selling out during the quarter.
Retirement Group sold 399 CorMedix shares in Q2 2021, an estimated $4K.
Retirement Group first reported a position in CorMedix in Q1 2021 and held it in 1 quarter.
Retirement Group's CorMedix position peaked at $4K in Q1 2021.
79 funds tracked by Wall St. Rank held CorMedix as of Q2 2021.

Based on Retirement Group's 13F filing for Q2 2021, filed 17 Aug 2021.